Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients. [electronic resource]
- Cancer treatment reports
- 59-64 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0361-5960
Antineoplastic Agents--therapeutic use Bleomycin--adverse effects Carcinoma, Bronchogenic--drug therapy Cyclophosphamide--adverse effects Drug Administration Schedule Drug Evaluation Drug Therapy, Combination Gastrointestinal Diseases--chemically induced Hematologic Diseases--chemically induced Humans Lung Neoplasms--drug therapy Nitrosourea Compounds--therapeutic use Semustine--adverse effects Vincristine--adverse effects